Pharma Mar, S.A. (LON:0RC6)
73.85
+0.40 (0.54%)
At close: May 9, 2025
Pharma Mar Revenue
Pharma Mar had revenue of 38.86M EUR in the quarter ending March 31, 2025, with 2.35% growth. This brings the company's revenue in the last twelve months to 175.75M, up 8.39% year-over-year. In the year 2024, Pharma Mar had annual revenue of 174.86M with 10.56% growth.
Revenue (ttm)
175.75M EUR
Revenue Growth
+8.39%
P/S Ratio
7.49
Revenue / Employee
351.49K EUR
Employees
500
Market Cap
1.10B GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 174.86M | 16.70M | 10.56% |
Dec 31, 2023 | 158.15M | -38.19M | -19.45% |
Dec 31, 2022 | 196.34M | -33.49M | -14.57% |
Dec 31, 2021 | 229.83M | -40.13M | -14.87% |
Dec 31, 2020 | 269.96M | 184.14M | 214.57% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 42.56B |
GSK plc | 31.53B |
Haleon | 11.23B |
Smith & Nephew | 4.64B |
ConvaTec Group | 1.83B |
Hikma Pharmaceuticals | 2.50B |
HUTCHMED (China) | 503.39M |
Genus | 671.60M |